BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Varian Medical Systems (VAR) Receives FDA 510(k) Clearance for the Edge™ Radiosurgery Suite


1/24/2013 6:36:19 AM

PALO ALTO, Calif., Jan. 24, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) has received FDA 510(k) clearance for the company's Edge radiosurgery suite, a new dedicated system for performing advanced radiosurgery using innovative real-time tumor tracking and motion management technologies.

"The Edge suite represents a new paradigm in radiosurgery, offering clinicians a system that combines Varian's world-class technologies in an end-to-end solution for planning and delivering radiosurgery treatments," said Chris Toth, vice president of marketing for Varian's Oncology Systems business. "It integrates Varian's state-of-the-art radiosurgery technology with tools for real-time imaging, tracking, and patient positioning. It enables fast, accurate delivery of stereotactic radiosurgery for treating lesions, tumors, and conditions anywhere in the body where radiotherapy is indicated, including tumors of the lung, prostate, spine and brain."

Recent FDA 510(k) clearances cover the following technologies that are integrated into the Edge radiosurgery suite. These new technologies are also being made available as upgrades to other compatible Varian systems:

  • The PerfectPitch couch: An integrated six degrees of freedom (6DoF) treatment couch that provides the accuracy, precision, and flexibility needed to position patients optimally, adjust their position to correct for any misalignments, and support them comfortably during treatment. The PerfectPitch couch has been designed for the accuracy and functionality required to deliver radiosurgery treatments in the brain and in the rest of the body.
  • The Advanced Motion & Image-Guided Radiotherapy (IGRT) package: An advanced motion management package that offers clinicians many options for using real-time imaging during radiotherapy treatments. It also enables expanded use of fluoroscopy and 4-D cone-beam CTimaging techniques that show motion over timeto better compensate for tumor motion during treatment.
  • Intracranial radiosurgery package: An integrated set of technologies for planning and delivering stereotactic radiosurgery treatments for tumors or functional abnormalities in the brain. The intracranial radiosurgery package supports the accurate delivery of radiation using multiple beam shaping options, including Varian's high-definition multileaf collimator and radiosurgery conical collimators, and is compatible with both frame-based and frameless patient immobilization approaches.
  • Calypso system: Several enhancements have been incorporated into the Calypso system for real time tracking. The system utilizes transponders, or position signaling devices, that are implanted in or around a tumor, or placed on the surface of the body and monitored to track motion during treatment. New enhancements increase the rate of transponder signal processing in order to track faster types of motion, such as respiratory motion, in real time. The system is also compatible with the couch rotations that are often used to optimize targeting during treatments in the lung. The new system also includes updated usability features designed to streamline treatments and enhance the user experience.

One optional Edge suite subcomponent is still pending FDA 510(k) clearance: Calypso anchored BeaconĀ® transpondersfor implantation in the lung to guide lung radiosurgery procedures.

Note to editors: high resolution images of the EDGE radiosurgery suite are available at this URL: http://varian.mediaroom.com/image-gallery?mode=gallery&cat=2874.

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing workstations for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications. Varian Medical Systems employs approximately 6,200 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.

FOR INFORMATION CONTACT:

Varian Medical Systems
Meryl Ginsberg, 650.424.6444
meryl.ginsberg@varian.com

SOURCE Varian Medical Systems



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->